Press Releases
Your resource for the latest Grifols news. You can search all published press releases by year and news category, or by using the search bar below.
Showing 195 search results
GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
Thomas Glanzmann becomes non-executive Chairman
GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339
Grifols Accelerates Performance in Q2 and Reaffirms Full Year Guidance
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
Grifols and Andorran government agree not to proceed with immunology research center
Grifols appoints Rahul Srinivasan as new Chief Financial Officer
Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Grifols discloses transfers of value made to European healthcare professionals and healthcare organizations in 2023
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
Grifols shareholders approve all agenda items at 2024 Annual General Meeting